William Brusilow is a notable inventor based in Grosse Pointe, MI (US). He has made significant contributions to the field of medical treatments, particularly in addressing diseases caused by inflammatory cytokine responses. With a total of 5 patents to his name, Brusilow's work has the potential to impact many lives.

Latest Patents

Brusilow's latest patents focus on the use of methionine sulfoximine (MSO) to treat diseases associated with inflammatory responses. His methods involve administering a diastereomer or diastereomeric mixture of methionine sulfoximine, which may include L-methionine S-sulfoximine (LSMSO), L-methionine R-sulfoximine (LRMSO), or a combination of both. These innovative methods are particularly aimed at treating liver failure linked to inflammatory responses.

Career Highlights

Throughout his career, Brusilow has worked with various companies, including Odessa Pharma. His expertise in the field has allowed him to develop groundbreaking treatments that address critical health issues.

Collaborations

Brusilow has collaborated with notable professionals in his field, including Paolo Bernardi. These partnerships have contributed to the advancement of his research and the development of effective treatment methods.

Conclusion

William Brusilow's innovative work in the treatment of inflammatory responses showcases his dedication to improving healthcare. His patents and collaborations highlight his significant contributions to medical science.